Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells

Hepatocellular carcinoma (HCC) is a complicated and poor prognosis cancer, necessitating the development of a potential treatment strategy. In this study, we initially revealed that LukS-PV belonged to leukocidin family performs an anti-HCC action. Then, we used liquid chromatography-mass spectromet...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chang-Cheng, Yu, Wen-Wei, Qi, Ying-Jie, Xu, Liang-Fei, Wang, Zi-Ran, Qiang, Ya-Wen, Ma, Fan, Ma, Xiao-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Preclinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028286/
https://www.ncbi.nlm.nih.gov/pubmed/31789624
http://dx.doi.org/10.1097/CAD.0000000000000866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028286/
https://www.ncbi.nlm.nih.gov/pubmed/31789624
http://dx.doi.org/10.1097/CAD.0000000000000866

Ejemplares similares